Retatrutide is an investigational peptide that acts as a triple hormone receptor agonist, targeting the GLP-1, GIP, and glucagon receptors. It is being studied for its potential to support appetite regulation, weight management, metabolic health, and energy balance through multiple complementary pathways.
 
Potential Benefits:
Supports appetite control and increased satiety
May promote significant weight loss and fat reduction
Supports healthy blood sugar and metabolic function
May improve energy expenditure and body composition
Supports long-term weight management when paired with proper nutrition and exercise
 
Retatrutide is intended for research purposes only and is not approved by the FDA for human consumption or therapeutic use.
 
Visit Pep-Pedia for more info